AprilBio Co.,Ltd. (KOSDAQ:397030)
11,410
0.00 (0.00%)
At close: Nov 17, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 313.88 billion as of November 16, 2026. It is the 19,384th most valuable company in the world and the 571st biggest in South Korea. Its market cap has decreased by 64.45% in one year.
Market Cap
313.88B
Enterprise Value
233.68B
Revenue
725.35M
Global Rank
Country Rank
#571 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 313.88B, an increase of 36.62%. That is a compound annual growth rate of 7.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 313.88B | -75.37% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JS Link | 577.59B |
| Qurient | 546.33B |
| Rznomics | 533.05B |
| Curocell | 327.38B |
| ROKIT Healthcare | 281.30B |
| Inventage Lab | 251.91B |
| S.Biomedics | 220.46B |
| IMBiologics | 189.17B |